PCI Pharma Services Expands U.S. Sterile Fill-Finish and Drug-Device Capabilities with $1B+ Investment
Supported by Over $1 Billion in Investment, PCI Pharma Services Unveils Major Expansion of U.S. Sterile Fill-Finish and Drug–Device Combination Capabilities PCI Pharma Services has unveiled an extensive series of…
Evofem Signs Exclusive Deal to Distribute and Commercialize SOLOSEC Across Sub-Saharan Africa
Evofem Signs Exclusive Deal to Distribute and Commercialize SOLOSEC Across Sub-Saharan Africa Evofem Biosciences, Inc., a biopharmaceutical company focused on advancing innovative solutions for women’s health, has announced a strategic…
Taiho Oncology, Taiho Pharmaceutical, and Araris Biotech Advance ADC Candidate ARC-02 into Phase 1 Clinical Trials
Taiho Oncology, Taiho Pharmaceutical, and Araris Biotech Advance ADC Candidate ARC-02 into Phase 1 Clinical Trials Taiho Oncology, Inc., together with Taiho Pharmaceutical Co., Ltd. and Araris Biotech AG, has…
vVARDIS Secures Investment from Apollo, Reaches Unicorn Valuation
vVARDIS Secures Strategic Investment from Apollo, Reaching Unicorn Valuation vVARDIS Holding AG, a rapidly expanding dental medtech innovator focused on transforming the way tooth decay is treated, has announced a…
Sun Pharma Enters Definitive Agreement to Acquire Organon
Sun Pharma Enters Definitive Agreement to Acquire Organon Sun Pharmaceutical Industries Limited and Organon & Co. have entered into a definitive agreement that marks one of the most significant consolidation…
Adagio Medical Reports Positive Pivotal Trial Outcomes for Its vCLAS® Ventricular Ablation System
Adagio Medical Reports Successful Pivotal Outcomes for vCLAS® Ventricular Ablation System Adagio Medical Holdings, Inc. has reported compelling six-month clinical outcomes from its pivotal FULCRUM-VT Investigational Device Exemption (IDE) trial,…
WuXi Biologics Completes Structure of Chengdu Microbial Manufacturing Facility as Key Equipment Arrives
WuXi Biologics’ Chengdu Microbial Manufacturing Facility Reaches Structural Completion with Key Equipment Installed WuXi Biologics has reached a major construction milestone in its global manufacturing expansion strategy, announcing the structural…
Johnson & Johnson Initiates Landmark Head-to-Head Trial of Pulsed Field Ablation in Persistent Atrial Fibrillation
Johnson & Johnson Initiates Pivotal Head-to-Head Trial of Pulsed Field Ablation in Persistent Atrial Fibrillation Johnson & Johnson has announced the initiation of a landmark clinical study aimed at advancing…
Dental Care Alliance Unveils Strategic Deal to Reinforce Financial Position and Drive Long-Term Growth
Dental Care Alliance Unveils Strategic Transaction to Bolster Financial Stability and Drive Long-Term Growth Dental Care Alliance (DCA), one of the largest dental support organizations in the United States, has…
Sunnybrook Health Sciences Centre Secures $41 Million Donation to Strengthen Canada’s Leadership in Clinical Trials
Sunnybrook Receives $41 Million Donation to Strengthen Canada’s Global Leadership in Clinical Trials Sunnybrook Health Sciences Centre has announced a transformative $41 million philanthropic investment aimed at reshaping the future…
Genentech Teams Up with Damon Wayans and diaTribe to Launch ‘All Eyes on DME’ Campaign Targeting Diabetes-Related Vision Loss
Genentech Collaborates with Damon Wayans and diaTribe to Raise Awareness of Diabetes-Related Vision Loss Through ‘All Eyes on DME’ Campaign Genentech, a member of the Roche Group, has introduced a…
Bristol Myers Squibb and Pfizer Partner with Mark Cuban Cost Plus Drug Company to Offer Eliquis® (apixaban)
Bristol Myers Squibb and Pfizer Partner with Mark Cuban Cost Plus Drug Company to Expand Access to Eliquis® (apixaban) The longstanding alliance between Bristol Myers Squibb and Pfizer has announced…